Rituximab-induced long-term remission in two children with SLE.
Jansson
Annette Friederike
AF
Dr. von Haunersches Kinderspital, Ludwig Maximilians University, Munich, Germany. annette.jansson@med.uni-muenchen.de
Wintergerst
Uwe
U
Renner
Ellen D
ED
Belohradsky
Bernd H
BH
D000974:Antibodies, Antinuclear / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D012074:Remission Induction / Q000379:methods*; D000069283:Rituximab; D013997:Time Factors
D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab